Skip to content

MaxCyte MXCT Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$4.75M+50.5%-$9.6M+22.7%-$12.42M-0.5%-$12.36M-20.4%-$10.26M+3.2%
$1.05M-2.3%$1.07M0.0%$1.07M-2.5%$1.1M+0.4%$1.1M+3.7%
$1.14M+61.6%$706K-63.9%$1.95M-44.4%$3.51M+15.6%$3.04M-3.0%
-$8.17M-204%-$2.69M+63.9%-$7.46M+24.3%-$9.85M+31.6%-$14.41M-84.3%
$72K-68.8%$231K-23.0%$300K-48.6%$584K-10.6%$653K+344%
$1.77M
$2.66M-72.6%$9.68M+86.4%$5.19M+238%$1.54M-83.9%$9.53M
$5K-95.2%$105K+650%$14K-90.9%$154K-59.8%$383K-7.0%
-$5.51M-$2.25M+72.4%-$8.16M-81.4%-$4.5M+50.4%
-$8.24M-182%-$2.92M+62.4%-$7.76M+25.7%-$10.44M+30.7%-$15.06M-89.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does MaxCyte generate?
MaxCyte (MXCT) generated -$28.2M in operating cash flow over the trailing twelve months.
What is MaxCyte's free cash flow?
After $1.2M of capital expenditures, MaxCyte's free cash flow was -$29.4M over the trailing twelve months, up 10.9% year over year.
Where does MaxCyte's cash flow data come from?
Every line is extracted from MaxCyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.